121 related articles for article (PubMed ID: 15722984)
1. What do heartburn sufferers expect from proton pump inhibitors when prescribed for the first time?
Kamolz T; Pointner R
Minerva Gastroenterol Dietol; 2004 Jun; 50(2):143-7. PubMed ID: 15722984
[TBL] [Abstract][Full Text] [Related]
2. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
Noar MD; Lotfi-Emran S
Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
[TBL] [Abstract][Full Text] [Related]
3. Treat or investigate?
Galmiche JP
Eur J Gastroenterol Hepatol; 1999 Jun; 11 Suppl 1():S11-5. PubMed ID: 10443907
[TBL] [Abstract][Full Text] [Related]
4. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
5. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
[TBL] [Abstract][Full Text] [Related]
6. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
7. Treatment of gastroesophageal reflux disease: defining endpoints that are important to patients.
Vakil N
Rev Gastroenterol Disord; 2004; 4 Suppl 4():S3-7. PubMed ID: 15580144
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.
Abu Farsakh N
J Gastroenterol; 2003; 38(11):1042-8. PubMed ID: 14673720
[TBL] [Abstract][Full Text] [Related]
9. Use of an endoscopic suturing device (the "ESD") to treat patients with gastroesophageal reflux disease, after unsuccessful EndoCinch endoluminal gastroplication: another failure.
Schiefke I; Neumann S; Zabel-Langhennig A; Moessner J; Caca K
Endoscopy; 2005 Aug; 37(8):700-5. PubMed ID: 16032486
[TBL] [Abstract][Full Text] [Related]
10. [Anti-reflux surgery in patients with adequate response to proton pump inhibitors - is there an indication?].
Horstmann R; Gregor N; Classen C; Röttgermann S; Palmes D
Z Gastroenterol; 2006 Dec; 44(12):1217-22. PubMed ID: 17163371
[TBL] [Abstract][Full Text] [Related]
11. Review article: alternative approaches to the long-term management of GERD.
Fennerty MB
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
[TBL] [Abstract][Full Text] [Related]
12. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
Bretagne JF; Rey JF; Caekaert A; Barthélemy P
Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis and reduces PPI use and esophageal acid exposure.
von Renteln D; Brey U; Riecken B; Caca K
Endoscopy; 2008 Mar; 40(3):173-8. PubMed ID: 18322871
[TBL] [Abstract][Full Text] [Related]
14. Endoluminal gastroplasty (EndoCinch) versus endoscopic polymer implantation (Enteryx) for treatment of gastroesophageal reflux disease: 6-month results of a prospective, randomized trial.
Domagk D; Menzel J; Seidel M; Ullerich H; Pohle T; Heinecke A; Domschke W; Kucharzik T
Am J Gastroenterol; 2006 Mar; 101(3):422-30. PubMed ID: 16542275
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
16. [Proton pump inhibitors according to need. Always for heartburn].
Labenz J
MMW Fortschr Med; 2002 Jun; 144(23):34-7. PubMed ID: 12119901
[TBL] [Abstract][Full Text] [Related]
17. Effect of gluten-free diet on preventing recurrence of gastroesophageal reflux disease-related symptoms in adult celiac patients with nonerosive reflux disease.
Usai P; Manca R; Cuomo R; Lai MA; Russo L; Boi MF
J Gastroenterol Hepatol; 2008 Sep; 23(9):1368-72. PubMed ID: 18853995
[TBL] [Abstract][Full Text] [Related]
18. Audit of reflux oesophagitis at 4 years.
Pace F; Bollani S; Manzionna G; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):355-60. PubMed ID: 9789126
[TBL] [Abstract][Full Text] [Related]
19. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
Fass R; Inadomi J; Han C; Mody R; O'Neil J; Perez MC
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):247-53. PubMed ID: 22155561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
